Track Bellevue Life Sciences Acquisition - Warrants (09/02/2028)'s minority interest ($21M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), BLACW shows a minority interest of $21M. That compares with $55M in the prior-year period — down 62.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BLACW's minority interest is now $21M (was $55M) — a 62.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bellevue Life Sciences Acquisition - Warrants (09/02/2028) is outperforming or lagging.
Tracking BLACW's minority interest over time shows whether Bellevue Life Sciences Acquisition - Warrants (09/02/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $21M That compares with $55M in the prior-year period — down 62.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this minority interest page, Stockcircle has Bellevue Life Sciences Acquisition - Warrants (09/02/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $21M) with ownership activity and broader fundamentals.